Screener
Bristol-Myers Squibb BMY Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Acquired IPRD | — | 1,508 | 94 | 1,695 |
| Amortization of acquired intangible assets | 437 | 830 | 874 | 1,660 |
| Other (income)/expense, net | (61) | 494 | (28) | 833 |
| Total Expenses | 8,887 | 10,496 | 17,137 | 18,726 |
| Earnings/(Loss) before income taxes | 4,086 | 1,773 | 7,326 | 4,744 |
| Income tax provision | 770 | 460 | 1,331 | 969 |
| Net earnings/(loss) | 3,316 | 1,313 | 5,994 | 3,775 |
| Noncontrolling interest | (1) | 2 | — | 9 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Bristol-Myers Squibb's total costs & expenses?
- Bristol-Myers Squibb (BMY) reported total costs & expenses of $8.89B in Q2 2026.
- How has Bristol-Myers Squibb's total costs & expenses changed year-over-year?
- Bristol-Myers Squibb's total costs & expenses decreased by 15.3% year-over-year, from $10.5B to $8.89B.
- What is the long-term trend for Bristol-Myers Squibb's total costs & expenses?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's total costs & expenses has grown at a 0.4% compound annual growth rate (CAGR), from $38.29B to $38.87B.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue during a specific reporting period. It encompasses cost of goods sold, research and development investments, selling and administrative overhead, and other charges such as asset impairments or amortization. Monitoring this figure allows investors to assess the company's overall cost structure and operational efficiency relative to its top-line performance.
Ask your AI about Bristol-Myers Squibb's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude